Tandospirone, a 5-HT1A partial agonist is effective in treating anorexia nervosa: a case series

This case report details the therapeutic effects of tandospirone on two patients with anorexia nervosa, one with the restricting subtype (ANR), and another with the binge-eating/purging subtype (ANBP). A 22-year-old female patient with ANR and a 23-year-old female patient with ANBP were treated succ...

Descripción completa

Detalles Bibliográficos
Autores principales: Okita, Kyoji, Shiina, Akihiro, Nakazato, Michiko, Iyo, Masaomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606595/
https://www.ncbi.nlm.nih.gov/pubmed/23497393
http://dx.doi.org/10.1186/1744-859X-12-7
_version_ 1782264028514484224
author Okita, Kyoji
Shiina, Akihiro
Nakazato, Michiko
Iyo, Masaomi
author_facet Okita, Kyoji
Shiina, Akihiro
Nakazato, Michiko
Iyo, Masaomi
author_sort Okita, Kyoji
collection PubMed
description This case report details the therapeutic effects of tandospirone on two patients with anorexia nervosa, one with the restricting subtype (ANR), and another with the binge-eating/purging subtype (ANBP). A 22-year-old female patient with ANR and a 23-year-old female patient with ANBP were treated successfully with the 5-HT1A partial agonist tandospirone. After treatment, not only did both patients gain weight, they also showed improved scores on the Eating Disorder Examination Questionnaire. In addition, a 6-month follow-up showed maintenance of these effects. In this disorder, tandospirone may be an effective drug for long-term use with good patient compliance.
format Online
Article
Text
id pubmed-3606595
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36065952013-03-24 Tandospirone, a 5-HT1A partial agonist is effective in treating anorexia nervosa: a case series Okita, Kyoji Shiina, Akihiro Nakazato, Michiko Iyo, Masaomi Ann Gen Psychiatry Case Report This case report details the therapeutic effects of tandospirone on two patients with anorexia nervosa, one with the restricting subtype (ANR), and another with the binge-eating/purging subtype (ANBP). A 22-year-old female patient with ANR and a 23-year-old female patient with ANBP were treated successfully with the 5-HT1A partial agonist tandospirone. After treatment, not only did both patients gain weight, they also showed improved scores on the Eating Disorder Examination Questionnaire. In addition, a 6-month follow-up showed maintenance of these effects. In this disorder, tandospirone may be an effective drug for long-term use with good patient compliance. BioMed Central 2013-03-09 /pmc/articles/PMC3606595/ /pubmed/23497393 http://dx.doi.org/10.1186/1744-859X-12-7 Text en Copyright ©2013 Okita et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Okita, Kyoji
Shiina, Akihiro
Nakazato, Michiko
Iyo, Masaomi
Tandospirone, a 5-HT1A partial agonist is effective in treating anorexia nervosa: a case series
title Tandospirone, a 5-HT1A partial agonist is effective in treating anorexia nervosa: a case series
title_full Tandospirone, a 5-HT1A partial agonist is effective in treating anorexia nervosa: a case series
title_fullStr Tandospirone, a 5-HT1A partial agonist is effective in treating anorexia nervosa: a case series
title_full_unstemmed Tandospirone, a 5-HT1A partial agonist is effective in treating anorexia nervosa: a case series
title_short Tandospirone, a 5-HT1A partial agonist is effective in treating anorexia nervosa: a case series
title_sort tandospirone, a 5-ht1a partial agonist is effective in treating anorexia nervosa: a case series
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606595/
https://www.ncbi.nlm.nih.gov/pubmed/23497393
http://dx.doi.org/10.1186/1744-859X-12-7
work_keys_str_mv AT okitakyoji tandospironea5ht1apartialagonistiseffectiveintreatinganorexianervosaacaseseries
AT shiinaakihiro tandospironea5ht1apartialagonistiseffectiveintreatinganorexianervosaacaseseries
AT nakazatomichiko tandospironea5ht1apartialagonistiseffectiveintreatinganorexianervosaacaseseries
AT iyomasaomi tandospironea5ht1apartialagonistiseffectiveintreatinganorexianervosaacaseseries

Ejemplares similares